High-level eukaryotic genomes present a particular challenge to the computational identication of transcription factor binding sites (TFBSs) because of their long noncoding regions and large numbers of repeat elements. This is evidenced by the noisy results generated by most current methods. In this paper, we present a p-value-based scoring scheme using probability generating functions to evaluate the statistical signi cance of potential TFBSs. Furthermore, we introduce the local genomic context into the model so that candidate sites are evaluated based both on their similarities to known binding sites and on their contrasts against their respective local genomic contexts. We demonstrate that our approach is advantageous in the prediction of myogenin and MEF2 binding sites in the human genome. We also apply LMM to large-scale human binding site sequences in situ and found that, compared to current popular methods, LMM analysis can reduce false positive errors by more than 50% without compromising sensitivity. This improvement will be of importance to any subsequent algorithm that aims to detect regulatory modules based on known PSSMs.
Efforts on the computational prediction of TFBSs fall into two general approaches. The rst seeks novel recurrent patterns in a set of DNA sequences, often the promoters of genes found to be coregulated in gene expression microarray experiments. A number of statistical models have been developed in the past decade for this purpose based on Bayesian models and Monte Carlo methods (Bailey and Elkan, 1994; Hughes et al., 2000; Lawrence et al., 1993; Lawrence and Reilly 1990; Liu et al., 2001; Liu et al., 2002; Roth et al., 1998) . They have been widely applied and found to be most successful in lower organisms such as bacteria and yeast. However, in higher organisms such as the human, these methods may yield noisy results because of the long noncoding regions and the large numbers of nonfunctional repeat elements (Lander et al., 2001) . A recent trend to improve upon these de novo methods is to incorporate the information from cross-species comparisons.
The other major approach to predict transcription factor binding sites makes use of prior knowledge on the binding sites. These methods evaluate individual candidate site sequences by their similarities to clusters of experimentally determined binding sites (Chen et al., 1995; Hertz et al., 1990; Quandt et al., 1995; Stormo and Hartzell, 1989; Wingender et al., 2000) . These binding site sequences are most often summarized using position-speci c scoring matrices (PSSMs), which are used to summarize the sequence patterns and to compare against candidate DNA segments. This is the approach of interest in this paper.
Various methods exist to score candidate segments for their similarities to known binding sites using PSSMs. We provide an example in Fig. 1 using the transcription factor myogenin. PSSM construction begins by using the alignment of known binding site sequences and tabulating the nucleotide distribution matrix (Fig. 1a) . The counts are then transformed using either of two related schemes, log-odds (Fig. 1b) or entropy (Fig. 1c) , to generate the PSSM. Candidate sites are scored against the PSSMs by summing over the corresponding scores of the nucleotides across the site sequence; i.e., the score of candidate site S D S 1 : : : S p against PSSM is .w ij / p£4 is S D P positioni w iS i . In practice, these scores are then compared to some predetermined cutoff values to generate computational TFBS predictions. Note that the most widely used database of transcription factor binding, TRANSFAC (Wingender et al., 2000) , is based on entropy-weighted PSSMs.
While probabilities are used in the construction of the PSSMs, the scores themselves cannot be interpreted statistically. This has led to the general dif culty with choosing the score cutoff values for each matrix, a problem that may have contributed to the large numbers of false positive predictions seen in practice. We propose a p-value based scoring scheme, which evaluates the statistical signi cance of the candidate site segment. This should apply to both the entropy-based and the log-odds-based scoring methods. However, in order to obtain a valid p-value, one needs to model the background sequence properly, which may serve either as the "null model" or a component in computing the log-odds scoring function.
In this paper, we model the background sequences, or the "null distribution," as a Markov chain. As in previous methods, candidate binding site sequences are scored by PSSMs. Each score is evaluated statistically by computing its p-value, that is, the probability that the background model can achieve a score at least as high as that observed. In order to calculate this p-value, we develop an ef cient and exact algorithm based on probability-generating functions that can achieve up to 1000-fold speed up compared to Monte Carlo simulations. We note that in contrast to score-based evaluation, the p-values we generate can serve as a universal measure of statistical signi cance of all candidate binding sites regardless of their corresponding binding factor or of their genomic locations.
It has been known that the effectiveness of a binding site in recruiting its corresponding transcription factors can be dramatically affected by the genomic context that it is in. This can be attributed to a number of factors such as the local DNA bending, the accessibility of the binding site, or the positive or negative effects of neighboring TFBSs. We incorporate the local genomic context into the p-value-based scoring method and develop the Local Markov Method (LMM). The p-value for a candidate site provides a measure of its similarity to known binding sites and its contrast against the local genomic context. We rst show that the incorporation of the local genomic context can be advantageous in the prediction of myogenin and MEF2 binding sites in the human genome, an advantage observed independently of the method of PSSM construction. We further compare the abilities of LMM and TRANSFAC to pick up 101 experimentally determined TFBSs from large tracts of human genomic sequences and nd that LMM can identify TFBSs with more speci city (50% fewer false positive predictions) without compromising sensitivity. The LMM software is available upon request (www.biostat.harvard.ed/ complab/LMM). 
MAIN RESULTS

p-value calculation
In order to calculate the probability that a given Markov background model can achieve a score at least as high as the observed score of the candidate site, we extend a previous method designed for a similar purpose but applicable only to the independent and identically distributed (iid) background sequence model (Staden, 1989) . The key part for this method is the reformulation of the distribution of the score as a probability-generating function which leads to an ef cient algorithm for its computation. We formulate the score probability-generating function under Markov models (detailed in the Detailed Methods section) and derive an algorithm with time complexity linear in the length of the PSSM, a dramatic improvement over the naive enumeration method which has time complexity exponential in the length of the PSSM.
FIG. 2. TRANSFAC vs. local Markov model (LMM)
in the identi cation of transcription factor binding sites (TFBSs) in a given genomic sequence. (a) TRANSFAC scans a genomic sequence, generates similarity scores of each subsequence against a given PSSM, and uses three matrix-speci c cutoffs FN, FP, and SUM to make putative calls. The three sets of cutoffs attempt to minimize false-negative error, false-positive error, or the sum of these two errors, respectively. (b) LMM begins by selecting the top 0.1% candidate sites based on their PSSM similarity scores, since sites with low similarity scores are unlikely to be true binding sites. For each candidate TFBS, LMM models the DNA sequence segment of length L (e.g., 1,000) centered around the target site as a homogeneous Markov chain of orders k D 0, 1, 2, or 3. Under the estimated Markov model, LMM calculates the probability distribution of the similarity score using our algorithm. This distribution then allows us to assign statistical signi cance to the given candidate TFBS.
We implement the algorithm in C and incorporate the program into the local Markov method (LMM) program to study TFBSs in situ by evaluating each candidate binding site with respect to its local genomic context. A summary of the LMM method is in Fig. 2b . For comparison, we also describe in Fig. 2a the prediction program which accompanies the TRANSFAC database.
To assess the ef ciency of our algorithm, we compare it against Monte Carlo simulations. Our experiments showed that the ef ciency of our approach can be many times more ef cient than Monte Carlo simulation. For example, at p · 0:0001, a sequence of length at least 10 9 basepairs needs to be simulated in order to obtain a suf ciently accurate cutoff value (relative error · 1%), which needs more than 1000-fold more computing time than our exact algorithm (Table 1) .
APPLICATIONS
MYL1 3
0 enhancer myogenin binding site prediction
In human, mouse, and rat, there is a well-conserved 200bp-long skeletal muscle-speci c enhancer about 24 kb 3 0 of MYL1 (Rosenthal et al., 1990; Wentworth et al., 1991) . Three myogenic determination factor binding sites A, B, and C are found in this region which are located 1267 bp, 1323 bp, and 1339 bp, a For 10 randomly chosen intergenic regions, we estimate a 2nd-order Markov model for each sequence using maximum likelihood estimation. Under the 10 estimated Markov models, we use our algorithm to derive and Monte Carlo simulation to estimate the score cutoffs of the p53 PSSM at two signi cance levels, p · 0:001 and p · 0:0001, on a 1,500 MHz AMD Athlon machine running Linux. To assess the difference between the cutoffs C p derived by our algorithm and the cutoffs C p estimated by simulations, we consider the p-value F .C p / attained by C p and the true p-value F .C p / of C p derived using our algorithm. We assess the relative errors of the simulation estimate by calculating
respectively, downstream of the last exon of MYL1 in the human genome. Sites A and B are myogenin/myf4 binding sites (Rosenthal et al., 1990) , while site C is a MyoD binding site (Wentworth et al., 1991) , also considered to be a myogenin binding site (Fickett, 1996) . We applied the LMM to the 10,000 bp MYL1 downstream region (starting from the end of the last exon) to derive the local p-values for each candidate. The local p-value for each candidate is the statistical signi cance of observing its score (derived by both log-odds and entropy-related PSSMs) assuming that it is generated under a local random model, where Markov models of different orders (e.g., 0, 1, or 2) are used and with parameters estimated from the local 1,000 bp genomic sequence centered at the candidate. The top 10 score candidate sites derived using log-odds or entropy-weighted PSSMs are listed in Table 2a and 2b, 
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respectively, with the true sites A, B, and C labeled and shaded in gray, along with their local p-values. We nd the PSSM scores to be less sensitive a measure than the local p-value: the true sites A, B, and C stood out under the local p-values, while they are not as distinct from the false predictions under the PSSM scores.
PGAM-M MEF2 binding site prediction
A major positive regulatory element is required for the muscle-speci c expression of the muscle-speci c subunit of the human phosphoglycerate mutase (PGAM-M) gene (Nakatsuji et al., 1992) . This element, located 161 bp upstream of the gene, is found to be bound by the transcription factor MEF-2.
We applied the LMM to the 5,000 bp PGAM-M upstream region using the MEF2_Q6 PSSM to derive the local p-values for each candidate. The top 10 score candidate sites derived using log-odds or entropyweighted PSSMs are listed in Tables 2c and 2d , respectively, with the true site labeled and shaded in gray, along with their local p-values. We nd that LMM behaves similarly as in the MYL1 enhancer.
Overall, from Table 2 , we see that by taking into account the local sequence composition we have reordered the candidate sequences in a way that is favorable to the true binding sites.
LARGE-SCALE VALIDATION
In order to evaluate the performance of LMM and to compare our local p-values to PSSM similarity scores, we apply both LMM and TRANSFAC to 101 known binding sites in the human genome obtained by mapping binding sites in the TRANSFAC database onto the human genome. We recorded and evaluated the extent to which LMM and TRANSFAC can capture this large collection of known binding sites in the human genome and the amount of noise generated in so doing.
In Figure 3a , the trade-off between sensitivity and noise is shown, in terms of the proportion of the known binding sites detected and the amount of concomitant noise generated. Noise is measured by the noise-to-signal ratio, which is de ned as the number of binding site calls not known to be correct divided by the number of known binding sites found. For comparison, we show the tradeoffs achieved by TRANSFAC using its three matrix-speci c similarity score cutoffs (FN, SUM, FP) along with that achieved by LMM under Markov models of orders 0, 1, 2, and 3 at various p-value cutoffs starting at the stringent p D 0:00001. From the inset graph, we see that at all levels of sensitivity, LMM outperformed TRANSFAC 
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by producing signi cantly less noise. While the performance of LMM comes close to that of TRANSFAC as the p-value cutoff increases, in fact, by then, for both methods, the advantage of increased sensitivity has been nulli ed by the high level of accompanying noise, rendering them impractical. Overall, not only is the sensitivity of LMM comparable to TRANSFAC, its noise-to-signal ratio is also vastly superior. It should be noted that since only a limited number of true binding sites are known, not every unsupported binding site prediction is necessarily a false-positive prediction. Thus, the noise-to-signal ratio overestimates the true noise level, especially when stringent criteria are used to generate putative TFBSs with high sequence similarity to known binding sites. As the criteria relax, the large numbers of predictions over and above the known binding sites imply a high level of true background noise.
More detailed results for TRANSFAC using the three cutoffs and for LMM using different signi cance cutoffs, 0.00001 and 0.0002, and under different Markov models are summarized in Fig. 3b . While the FN cut off missed relatively few known binding sites, it generated more than 45 false-positive predictions for every accurate binding site call. On the other hand, FP made fewer false positives, but it detected only one in nine known binding sites. The SUM cutoff, designed as a balance of these inherent tradeoffs, did strike a reasonable compromise, having generated about nine false positives for every real binding site and detected more than half of the known sites.
At the stringent signi cance cutoff p D 0:00001, LMM detected about twice the binding sites than did the FP cutoff and on average produced about 60% fewer false-positive predictions for every correct prediction. At the more relaxed p-value cutoff p D 0:0002, the sensitivity of LMM is comparable to that of the SUM cutoff while only half of the noise is generated. The binding sites that were detected by LMM at p · 0:0002 but missed by TRANSFAC using the SUM cutoff include a MEF2 binding site over the desmin gene, an ATF1 (activating transcription factor 1) binding site over the TGF¯2 gene, a HIF (hypoxia-inducible factor) binding site over the VEGF gene, and an ICSBP (IFN consensus sequence binding protein) binding site over the OAS1 gene. We choose p D 0:0002 as the general signi cance cutoff for the application of LMM to mammalian genomic sequences, a cutoff with a suf ciently high sensitivity and an acceptable amount of noise. Overall, the LMM provides an advantageous tradeoff between noiseto-signal ratio and sensitivity.
In our validation experiment, we found that Markov models of orders 1, 2, and 3 have better combinations of high sensitivity and low noise than the iid model, con rming an earlier observation (Liu et al., 2001 ) that Markov models can better capture the structure of biological sequences. In addition, we compared   FIG. 4 . The use of local sequence context is advantageous. The performance of the second-order LMM is compared against an analogous global Markov model with parameters estimated from a large collection of upstream regions. The performance is assessed in terms of the noise-to-signal ratio and sensitivity. At the recommended p-value cutoff 0.0002, LMM is more sensitive and less noisy.
the performance of the second-order LMM against an analogous global Markov model with parameters estimated from a large collection of upstream regions, in order to assess the ability of LMM to model the local sequence context information. We found that over the 101 known human TFBSs in situ, LMM generally outperforms the global Markov model, while they behave similarly at high and low sensitivity levels (Fig. 4) . At high sensitivity levels, the lax p-value cutoffs produce large numbers of putative TFBS calls, overwhelming the advantage enjoyed by LMM. At low sensitivity levels, the stringent p-value cutoffs yield only putative TFBSs with undeniable sequence similarity to known binding sites. Thus, the noise-to-signal ratio may not re ect the true noise level in this region.
DISCUSSION
The work presented in this paper attemps to identify TFBSs by considering simultaneously both their similarity to the query PSSM and their differences from the local genomic context. Through the study of the human TFBSs in TRANSFAC, we show that LMM, which makes putative TFBS calls using local p-values, yields a much improved false-positive to true-positive ratio than that using the TRANSFAC or log-odds scores alone.
It has been known that neighboring nucleotide compositions can affect the interaction between a transcription factor and its binding site. To our best knowledge, however, there is no documented study on whether and how much an improvement can be made on the PSSM-based TFBS detection using a local background model. The result we present, which is based on more than 100 experimentally determined TFBS sequences in the human genome, shows a clear overall advantage for incorporating the local sequence context into PSSM-based TFBS search. There are various biological mechanisms that can explain this effect, which may lead to more complicated and more speci c models. For instance, it may be that the local 1,000 bp genomic region does not contain DNA sequences similar to the true binding site because otherwise the target transcription factor may be competed away from its biologically meaningful binding site.
While this improvement does not in itself render a solution to the much more dif cult problem of detecting regulatory modules, by signi cantly reducing false-positive calls for single sites, the local pvalue approach will contribute substantially to any subsequent algorithms aiming to detect combinatorial regulatory modules. The method we developed here is seen as a proof of principle and can be used as a component of a more complex approach. For example, considering that clusters of binding sites also often occur within small regions of about 200 bp to cooperatively recruit the transcription factors, a natural future development of LMM would be to take this distance effect into the background estimation and combine the LMM p-values of a few candidate PSSM sites. Many challenging problems in computational biology, e.g., translation initiation site identi cation, splice site recognition, and RNA secondary structure prediction, can be modeled in terms of the recognition of motifs. Our work may be adapted and extended to these problems as well. However, it should be noted that when applied to protein sequences, which are composed of a 20-letter alphabet, the performance of our algorithm may become an issue, especially when the order of the Markov chain k is large.
DETAILED METHODS
Data extraction for large-scale validation
To evaluate the performance of the LMM, we apply it to known TFBSs in the human genome. Known binding sites are extracted from the SITE table of the TRANSFAC database version 6.2. About half of the 12,262 binding sites in this table are experimentally derived from various species. The rest are generated from in vitro binding assays on arti cial nucleotide sequences. Since LMM studies binding sites with respect to their genomic contexts, these arti cial sequences, which do not correspond to any genomic region, cannot be used for our validation study. Of the 6,073 in vivo binding sites, 1,425 sites are based on the human genome. Of these, 149 (10.5%) are annotated with a corresponding PSSM. We use these binding sites for validation.
To locate the known TFBSs in the human genome, we focus on the 5,000 bp upstream sequences of all genes. We made use of the annotations provided by Ensembl (Hubbard et al., 2002) and extracted 22,808 human gene promoters from the human genome assembly NCBI golden path 29 (www.ensembl.org/Homo_ sapiens). Since heuristic sequence-mapping algorithms do not perform well on short sequences such as TFBSs, we use an exact-match algorithm based on suf x trees (Gus eld, 1997). We found that many binding site sequences are precisely mapped onto the promoters of the correct target genes. For those binding sites with mappings onto multiple promoters or with no mapping, we attempted to retrieve them by manual review. To nd the correct one among multiple mappings, we made correspondences between the Ensembl gene name and the target gene name of the binding site as recorded by TRANSFAC. A review of some missed matches using inexact match algorithms revealed a small number of single-basepair differences between the recorded binding site sequences and the promoter sequences of the target genes, for example, the binding site HS$ALBU_06 over the human albumin promoter. After validating against the primary literature for the positions of these binding sites, we included these mappings as well. In total, we located 101 human TFBSs.
Local p-value calculation
Although the exact score distribution can be obtained by enumerating all possible binding site sequences under any "null" model for the observed nucleotide base pairs, the computational cost for a PSSM of length p is 4 p . Staden's method (Staden, 1989) , which turns this into an order-p computation, is based on the PGF of the score under the simple null model that the base pairs are independent and identically distributed (iid). Recently, however, there are some evidences suggesting that Markov background models work better than the iid model for detecting TFBS (Liu et al., 2002) . By extending Staden's PGF method to dependent random variables, we present here the derivation of the PGFs under a rst-order Markov model, the basis of the ef cient algorithm for computing the exact score distribution.
Probability generating function derivation
In our study, we make use of the PSSMs constructed by TRANSFAC version 6.2. Given a PSSM m D .w ij / p£4 , where i D 1; : : : ; p and j D A,C,G,T, the match score S and the similarity score S=S max of a sequence D 1 D 2 : : : D p is de ned as (Quandt et al., 1995) S D Let S be a random variable taking integer values; then its probability generating function, G.t /, is the expected value of t S , G.t/ is a polynomial, and the coef cient of the term t n is the probability of the event S D n (Gut, 1995) .
Given a PSSM m of length p, under the assumption that the DNA sequence is iid, Staden provided the PGF of the match score in the form of a product of p polynomials (Staden, 1989) 
where M.i; t / D Diag.t w iA ; t w iC ; t w iG ; t w i T /; and I D .1; 1; 1; 1/ T (proof provided at the end of this section).
Since a Markov chain of order k on set 0 is equivalently a rst-order Markov chain on the set 0 k , with a little modi cation on M.i; t/, we can generalize the above results to k > 1. An example of PGF for k D 3 is in the online supplement (www.biostat.harvard.edu/complab/LMM). Using this representation for the PGF, we developed and implemented an algorithm using CCC to calculate the exact score distribution. Generally, for a kth-order Markov chain and a PSSM of length p, the time complexity of our algorithm is O.4 k ¢ S max ¢ p/, linear in the matrix length but exponential in the order of the Markov chain. The source code is available upon request (www.biostat.hsph.harvard.edu/LMM).
